Inspire Medical Systems (INSP) Depreciation & Amortization (CF) (2017 - 2026)

Inspire Medical Systems has reported Depreciation & Amortization (CF) for 10 years, with the latest figure at $5.1 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 67.87% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.0 million (up 83.02% YoY) and the FY2025 annual result came in at $14.0 million, up 113.08% from the prior year.
• Depreciation & Amortization (CF) improved to $5.1 million in Q1 2026 per INSP's latest filing, from $3.8 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $5.1 million in Q1 2026 and troughed at $359000.0 in Q1 2022.
• A 5-year average of $1.8 million and a median of $839000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) surged 37.17% in 2022, then soared 262.81% in 2025.
• Over 5 years, Depreciation & Amortization (CF) stood at $569000.0 in 2022, then soared by 43.59% to $817000.0 in 2023, then surged by 203.3% to $2.5 million in 2024, then soared by 54.24% to $3.8 million in 2025, then soared by 33.7% to $5.1 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $5.1 million, $3.8 million, and $3.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.